Blog

NULL Read More ​ NULL NULL  Moneycontrol Latest News Read More   NULL

NULL Read More ​ NULL NULL  Moneycontrol Latest News Read More   NULL

NULL Read More ​ NULL NULL  Moneycontrol Latest News Read More   NULL

The Congress#39; attack on the government came after Union Home Minister Amit Shah#39;s reported remarks that there is nothing for the Bharatiya Janata Party (BJP) to hide or be afraid of in the matter. Read More ​ The Congress#39; attack on… Read More »If nothing to hide, why govt running away from JPC probe into Adani issue: Jairam Ramesh

NULL Read More ​ NULL NULL  Moneycontrol Latest News Read More   NULL

However, earthquake prediction has never been achieved successfully in a way which could be repeated. Read More ​ However, earthquake prediction has never been achieved successfully in a way which could be repeated. However, earthquake prediction has never been achieved successfully… Read More »Nobody can predict earthquakes, but we can forecast them. Here#39;s how

Jefferies has kept a base case target price of Rs 3,620 while in an upside scenario, the stock could hit Rs 4,000 even. Read More ​ Jefferies has kept a base case target price of Rs 3,620 while in an upside… Read More »ABB India extends gains as analysts see demand outlook improving

Companies are earning much higher interest income on customer cash advances, cushioning them against an economic slowdown Read More ​ Companies are earning much higher interest income on customer cash advances, cushioning them against an economic slowdown Companies are earning much… Read More »Why Warren Buffett should love Robinhood

When Covid was raging, couples had generally not been willing to travel, preferring to stay home to celebrate Valentine#39;s Day. This year, they are seeking experiential holidays and staycations, to explore nature and wildlife. Read More ​ When Covid was raging,… Read More »Hotels see surge in demand for Valentine#39;s Day, expect day of love to drive business

Nomura has a #39;buy#39; rating for Glenmark Pharma with a target price of Rs 633 Read More ​ Nomura has a #39;buy#39; rating for Glenmark Pharma with a target price of Rs 633 Nomura has a #39;buy#39; rating for Glenmark Pharma… Read More »Glenmark Pharma surges as Nomura raises target price, sees 50% upside